Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 11Thoracic 6Gynecologic 4Tumor-Agnostic 3Head & Neck 2CNS 2Sarcoma 1Genitourinary 1Endocrine 1

Conditions

Squamous Cell Carcinoma of Head and Neck 281Head and Neck Neoplasms 258Nasopharyngeal Carcinoma 127Oropharyngeal Neoplasms 57Carcinoma, Squamous Cell 54Nasopharyngeal Neoplasms 41Laryngeal Neoplasms 35Mouth Neoplasms 30Hypopharyngeal Neoplasms 29Carcinoma 24Salivary Gland Neoplasms 19Carcinoma, Non-Small-Cell Lung 16Tongue Neoplasms 15Neoplasm Metastasis 13Laryngeal Diseases 13Recurrence 12Neoplasms 10Parkinson Disease 4, Autosomal Dominant Lewy Body 8Mucositis 8Stomach Neoplasms 7Pharyngeal Neoplasms 7Papillomavirus Infections 7Ovarian Neoplasms 7Lung Neoplasms 7Radiation Injuries 6Pancreatic Neoplasms 6Neoplasms, Squamous Cell 6Esophageal Neoplasms 6Colorectal Neoplasms 6Thyroid Neoplasms 5

Interventions

pralsetinib 2pembrolizumab 2Cisplatin 2trastuzumab deruxtecan 1repotrectinib 1liposomal doxorubicin 1cabozantinib 1bicalutamide 1atezolizumab 1Triptorelin Pamoate 1Radiotherapy 1Radiation 1Quality of Life 1Pemetrexed 1Patient Reported Outcome Measures 1Paclitaxel 1Molecular Diagnostic Techniques 1Immunotherapy 1Gemcitabine 1Drug Therapy 1Doxorubicin 1Carboplatin 1CP protocol 1Biological Therapy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Adenocarcinoma × Cisplatin × Head & Neck × Clear all
NCT04222972 2026-03-05

AcceleRET-Lung

Hoffmann-La Roche

Phase 3 Terminated
223 enrolled 18 charts
Head & NeckThoracic

Adenocarcinoma, Bronchial Diseases, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT01969578 2024-11-05

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
149 enrolled
Head & Neck

Adenocarcinoma, Salivary Gland Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡